Clinicopathological characteristics of primary lung adenocarcinoma predominantly composed of goblet cells in surgically resected cases

被引:24
作者
Ichinokawa, Hideomi [1 ,2 ,3 ]
Ishii, Genichiro [1 ]
Nagai, Kanji [2 ]
Yoshida, Junji [2 ]
Nishimura, Mitsuyo [2 ]
Hishida, Tomoyuki [2 ]
Suzuki, Kenji [3 ]
Ochiai, Atsushi [1 ]
机构
[1] Natl Canc Ctr Hosp E, Res Ctr Innovat Oncol, Div Pathol, Chiba 2778577, Japan
[2] Natl Canc Ctr Hosp E, Div Thorac Oncol, Chiba 2778577, Japan
[3] Juntendo Univ, Sch Med, Tokyo 113, Japan
关键词
adenocarcinoma; goblet cell component; local recurrence; mucinous BAC; MUCINOUS BRONCHIOLOALVEOLAR CARCINOMA; CYSTIC ADENOMATOID MALFORMATION; CLINICAL CHARACTERISTICS; KRAS MUTATION; EGFR; ASSOCIATION; EXPRESSION; SUBTYPES; CANCER; TRIAL;
D O I
10.1111/j.1440-1827.2011.02677.x
中图分类号
R36 [病理学];
学科分类号
100103 [病原生物学];
摘要
Primary lung adenocarcinomas predominantly composed of goblet cells (APGC) are relatively rare, and the clinicopathological characteristics have remained unclear. The aim of this study was to clarify the clinicopathological characteristics of APGC. We selected adenocarcinoma with a goblet cell-type component of >= 90% from 2228 cases of surgically resected primary lung adenocarcinoma. The clinicopathological characteristics of APGC (46 cases) were analyzed. APGC showed a significantly higher rate of tumor location on the left side, in the lower lobe and pathological stage I, when compared with the other types of adenocarcinoma. Furthermore, APGC displayed a lower frequency of central fibrosis, plural invasion, pulmonary metastasis, lymphatic permeation, and vascular invasion. APGC showed local recurrence in two of 46 cases (4.3%) and no incidents of distant metastasis. When compared with non-mucinous bronchioloalveolar adenocarcinomas (non-mucinous BAC) without central fibrosis, APGC without central fibrosis, corresponding to mucinous BAC, showed a significantly higher rate of tumor location on the left side and in the lower lobe. In conclusion, APGC formed a distinct subset and should be considered separately from lung adenocarcinoma based on frequent involvement of the left and lower lung and lack of central fibrosis.
引用
收藏
页码:423 / 429
页数:7
相关论文
共 28 条
[1]
Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung [J].
Awaya, H ;
Takeshima, Y ;
Yamasaki, M ;
Inai, K .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 121 (05) :644-653
[2]
IFCT-0401 Trial A Phase II Study of Gefitinib Administered as First-Line Treatment in Advanced Adenocarcinoma with Bronchioloalveolar Carcinoma Subtype [J].
Cadranel, Jacques ;
Quoix, Elisabeth ;
Baudrin, Laurence ;
Mourlanette, Pierre ;
Moro-Sibilot, Denis ;
Morere, Jean-Francois ;
Souquet, Pierre-Jean ;
Soria, Jean-Charles ;
Morin, Franck ;
Milleron, Bernard .
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) :1126-1135
[3]
Cloutier MM, 1995, CANCER, V75, P2844
[4]
COLBY T, 1995, TUMORS LOWER RESP TR, P203
[5]
Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features [J].
Finberg, Karin E. ;
Sequist, Lecia V. ;
Joshi, Victoria A. ;
Muzikansky, Alona ;
Miller, Julie M. ;
Han, Moonjoo ;
Beheshti, Javad ;
Chirieac, Lucian R. ;
Mark, Eugene J. ;
Iafrate, A. John .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2007, 9 (03) :320-326
[6]
GEMMA A, 1991, ACTA PATHOL JAPON, V41, P737
[7]
Frequency of EGFR and KRAS Mutations in Japanese Patients with Lung Adenocarcinoma with Features of the Mucinous Subtype of Bronchioloalveolar Carcinoma [J].
Hata, Akito ;
Katakami, Nobuyuki ;
Fujita, Shiro ;
Kaji, Reiko ;
Imai, Yukihiro ;
Takahashi, Yutaka ;
Nishimura, Takashi ;
Tomii, Keisuke ;
Ishihara, Kyosuke .
JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (08) :1197-1200
[9]
KOBAYASHI T, 1990, CANCER-AM CANCER SOC, V66, P289, DOI 10.1002/1097-0142(19900715)66:2<289::AID-CNCR2820660216>3.0.CO
[10]
2-6